Complete remission of a primary cutaneous follicle-center cell lymphoma (EORTC criteria)/diffuse large B-cell lymphoma (WHO criteria) by single first-line therapy with rituximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples